Start Your Journey Today

Start with the online assessment. A licensed provider reviews your evaluation (your Good Faith Exam), and if treatment is appropriate for you, you receive a payment link — you pay only after your assessment is approved. Your medication is then prepared by a licensed pharmacy and shipped to your home.

Yes. A healthcare provider must review your initial evaluation before any prescription is issued.

Yes. Semaglutide and Tirzepatide treatments described here are prescription medications and require provider approval.

GLP-1 treatment may be an option for adults who need to lose weight and have not reached their goals with diet and activity alone. Your provider decides case by case after reviewing your evaluation and health history. These medications are not for people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, and they are not used during pregnancy.

It varies from person to person. In clinical studies of the FDA-approved versions, average weight loss was about 15% of body weight with Semaglutide and up to about 21% with Tirzepatide over roughly 16–17 months, alongside a reduced-calorie diet and increased activity. Many people begin to notice changes in the first 4 to 8 weeks. Your provider will set realistic expectations for your case.

No. Individual results vary and no specific result or amount of weight loss is guaranteed.

The most common side effects are digestive: nausea, diarrhea, vomiting and constipation, especially while your dose is increasing. They are usually mild to moderate and often improve over time. Your provider will explain what to expect and when to get in touch. Read more →

Prices are published on each product page: Semaglutide starts at $125 per vial and Tirzepatide at $149 per vial, depending on the dose your provider prescribes. You pay only after your assessment is approved — there is no charge before a provider reviews your case.

PLUMP VIP is a self-pay program and does not bill insurance, so there are no coverage denials or waiting periods — your price is the published price.

Both support weight loss; Tirzepatide works on two hormone pathways (GIP and GLP-1) and showed the largest average weight loss in studies, while Semaglutide has a longer track record. Your provider will recommend the option that fits your health history and goals after your review. Compare both in depth →

Both medications are taken as a once-weekly injection at home. Your medication arrives with clear instructions, and your provider sets your dose and how it increases over time.

These are long-term treatments. In studies, many people regained a significant part of the weight after stopping, so it is best to plan treatment as an ongoing program and discuss any change with your provider first.